Genoox
Genoox is a clinical genomics software company that developed Franklin, an AI-powered cloud platform for storing, managing, and interpreting genetic variants for clinical laboratories and healthcare providers. Acquired by QIAGEN in 2025.
- Company typePrivate
- Founded2012
- HeadquartersPalo Alto, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Genoox does
Genoox is a clinical genomics software company that developed Franklin, an AI-powered cloud-based platform for storing, managing, searching, and interpreting genetic variants in clinical settings. Founded in 2012 in Tel Aviv, Israel, the company served clinical genomics laboratories and healthcare providers requiring scalable tools for variant interpretation. The Franklin platform processes VCF files and supports variant search and interpretation across SNP, CNV, and ROH data types, covering both germline and somatic contexts against reference genomes such as hg19. Genoox positioned Franklin as a community-driven platform intended to aggregate real-world evidence (RWE) from clinical genomic and clinical data, creating a data flywheel intended to improve variant interpretation accuracy over time.
The company operated a cloud-based SaaS distribution model with direct digital customer acquisition, primarily marketing through its Franklin platform website and community engagement channels targeted at genomic data professionals. Genoox was venture-backed, raising approximately $20 million across multiple funding rounds from 2014 through 2021, with investors including IN Venture, Glilot Capital Partners, Triventures, Inimiti, Infinity Medical, and UpWest. The company's co-founders were Amir Trabelsi (CEO) and Moshe Einhorn (CTO), with Ohad Arazi appointed Chairman of the Board in June 2021 to support growth and clinical reach. Genoox operated with a small team of 11-50 employees and did not publicly disclose its pricing model or specific revenue figures.
In July 2025, QIAGEN N.V. acquired Genoox for $70 million in cash as a bolt-on transaction to add the Franklin platform to QIAGEN's clinical genomics portfolio. The acquisition provides Genoox with QIAGEN's global clinical genomics distribution network, materially expanding the addressable market for Franklin's AI-powered variant interpretation capabilities. As of the acquisition, Genoox operates as a wholly-owned subsidiary of QIAGEN, with the Franklin platform integrated into QIAGEN's broader clinical genomics product suite to support precision medicine and clinical diagnostic workflows.
Genoox firmographics
Firmographics- Name
- Genoox
- Legal name
- Genoox Ltd.
- Website
- https://genoox.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Short description
- Genoox is a clinical genomics software company that developed Franklin, an AI-powered cloud platform for storing, managing, and interpreting genetic variants for clinical laboratories and healthcare providers. Acquired by QIAGEN in 2025.
- Ownership category
- akta.pro rank
Genoox industry classification
Industry- Product category
- Clinical Genomics Software
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Genomic Profiling & Sequencing-Based Precision Medicine (HLAAANAA)
- akta.pro secondary industries
- Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Molecular Cytogenetics & Genomic Variation Services (Karyotyping/FISH/aCGH/CNV) (HLAGANAJ)
Keywords
Where Genoox is headquartered
LocationHeadquarters
- HQ city
- Palo Alto
- HQ country
- United States
- HQ region
- North America
Markets served
Genoox business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Infrastructure, Personnel, Marketing or Sales, Operations
Genoox product offering
Product offeringCore offering
Genoox provides the Franklin platform, a cloud-based AI-powered software solution for storing, managing, searching, and interpreting clinical genomic data. The platform enables clinical genomics laboratories and healthcare providers to analyze genetic variants (SNP, CNV, ROH) for precision medicine applications. It supports germline and somatic variant interpretation across reference genomes including hg19.
Product overview
Genoox offers a cloud-based genomic data management and analysis platform centered around the Franklin product. Franklin is an AI-powered clinical genomics platform that enables variant interpretation and genomic data analysis. Following QIAGEN's acquisition of Genoox in July 2025 for $70 million, Franklin was integrated into QIAGEN's clinical genomics portfolio to enhance AI-powered variant interpretation capabilities and expand global reach in precision medicine.
Differentiator
Problem solved
Functional benefit
Brands
- Franklin: AI-powered genomic data interpretation platform for clinical variant analysis, now part of QIAGEN's clinical genomics portfolio.
Products and services
- Franklin Franklin is a cloud-based AI-powered genomic data platform for storing, managing, and interpreting genetic variants. It supports variant search using SNP, CNV, and ROH data types with germline analysis capabilities across different reference genomes (hg19), serving clinical genomics laboratories and healthcare providers performing precision medicine applications.
Companies that use Genoox
Customer profileSegments1 record
Ideal customer profiles1 record
Genoox technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature1 record
Genoox partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights5 records
Genoox competitors and assessment
Company assessmentDirect peers
- Fabric Genomics: AI-driven clinical genomics interpretation platform offering variant analysis and clinical reporting workflows; competes directly with Genoox's Franklin in serving clinical laboratories and hospitals needing scalable variant interpretation.
- DNAnexus: Cloud-based genomics data management and analysis platform used by clinical and research organizations; closely comparable to Genoox's Franklin in providing scalable cloud infrastructure for genomic data storage, search, and interpretation.
- BC Platforms: Genomics data management and interpretation platform serving clinical research and biobanking customers; comparable to Genoox in offering cloud-based genomic data infrastructure with built-in variant interpretation capabilities.
- Congenica: Clinical genomics interpretation platform with AI-augmented variant analysis for rare disease and precision medicine; directly competes with Genoox in serving clinical laboratories with genomic data interpretation.
- SOPHiA Genetics: Cloud-based AI platform for genomic and multimodal patient data analysis, used by hospitals and labs globally for variant interpretation; directly comparable to Genoox's Franklin in clinical NGS interpretation and rare disease/oncology workflows.
Emerging players
- GenomOncology: Precision oncology workflow software that combines variant interpretation with clinical decision support; overlaps with Genoox in clinical genomic interpretation but with a narrower oncology focus rather than Genoox's broader germline/somatic scope.
- Aranscia: Clinical genomics interpretation and reporting platform serving diagnostic laboratories; comparable to Genoox's Franklin in providing variant interpretation software for clinical workflows with a focus on hereditary disease testing.
- Diploid: AI-driven rare disease diagnosis platform that automates variant interpretation from NGS data; directly comparable to Genoox's Franklin in AI-based clinical interpretation for rare disease and pediatric genomics use cases.
Broad incumbents
- Emedgene (Illumina): AI-powered clinical variant interpretation platform now part of Illumina; competes with Genoox in automated clinical variant interpretation and is bundled with Illumina's dominant sequencing platform—creating a powerful incumbent competitor inside QIAGEN's market.
- PierianDx (now Illumina Connected Insights): Clinical genomics interpretation platform acquired by Illumina; offers overlapping variant interpretation and clinical reporting functionality to Genoox's Franklin, but as part of a larger sequencing ecosystem rather than a standalone specialist.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Genoox social profiles
Digital presenceGenoox financial estimates
Financial estimateRevenue estimate
Valuation estimate
Genoox leadership team
Management profileNumber of profiles
Profiles3 records
Genoox funding detail
Funding detailFunding overview
Funding rounds5 records
Investors8 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Genoox M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Genoox
What does Genoox do?
Genoox provides the Franklin platform, a cloud-based AI-powered software solution for storing, managing, searching, and interpreting clinical genomic data. The platform enables clinical genomics laboratories and healthcare providers to analyze genetic variants (SNP, CNV, ROH) for precision medicine applications. It supports germline and somatic variant interpretation across reference genomes including hg19.
Is Genoox a public or private company?
Genoox is a private company. It is classified as corporate owned and is currently acquired.
When was Genoox founded?
Genoox was founded in 2012. It employs 11 to 50 people.
Where is Genoox based?
Genoox is headquartered in Palo Alto, United States, in the North America region.
Who are Genoox's main competitors?
Direct peers on record are Fabric Genomics, DNAnexus, BC Platforms, Congenica and SOPHiA Genetics. Emerging players are GenomOncology, Aranscia and Diploid. Broad incumbents are Emedgene (Illumina) and PierianDx (now Illumina Connected Insights).
Does Genoox have an API?
No public API is recorded for Genoox.
What industry is Genoox in?
Genoox's product category is Clinical Genomics Software. Its primary akta.pro industry code is HLAAANAA, Genomic Profiling & Sequencing-Based Precision Medicine, with a secondary code of HLAAALAD, Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics). Its NAICS code is 541714 and its SIC code is 7372.